Search details
1.
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
J Infect Dis
; 229(3): 671-679, 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-37948759
2.
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
N Engl J Med
; 385(4): 330-341, 2021 07 22.
Article
in English
| MEDLINE | ID: mdl-34289276
3.
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).
Gene Ther
; 30(3-4): 216-221, 2023 04.
Article
in English
| MEDLINE | ID: mdl-34493840
4.
Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin.
Clin Infect Dis
; 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37982585
5.
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.
Clin Infect Dis
; 74(10): 1831-1839, 2022 05 30.
Article
in English
| MEDLINE | ID: mdl-34410358
6.
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.
Clin Infect Dis
; 75(10): 1781-1791, 2022 11 14.
Article
in English
| MEDLINE | ID: mdl-35396591
7.
Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
Clin Infect Dis
; 73(4): e870-e877, 2021 08 16.
Article
in English
| MEDLINE | ID: mdl-34398958
8.
Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa.
Malar J
; 20(1): 478, 2021 Dec 20.
Article
in English
| MEDLINE | ID: mdl-34930267
9.
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.
AIDS Res Ther
; 18(1): 17, 2021 04 21.
Article
in English
| MEDLINE | ID: mdl-33882938
10.
Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).
Gene Ther
; 30(3-4): 405, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-34584245
11.
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial.
Lancet Infect Dis
; 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38821073
12.
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Lancet Microbe
; 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38815595
13.
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.
Lancet Infect Dis
; 23(7): 847-855, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36966799
14.
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.
Lancet HIV
; 9(6): e381-e393, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35460601
15.
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).
Med
; 3(8): 531-537, 2022 08 12.
Article
in English
| MEDLINE | ID: mdl-35963234
16.
Facilitated transition in HIV drug trial closure: A conceptual model for HIV post-trial care.
PLoS One
; 16(4): e0250698, 2021.
Article
in English
| MEDLINE | ID: mdl-33914783
17.
Factors associated with virological non-suppression among HIV-positive children receiving antiretroviral therapy at the Joint Clinical Research Centre in Lubowa, Kampala Uganda.
PLoS One
; 16(1): e0246140, 2021.
Article
in English
| MEDLINE | ID: mdl-33503074
18.
Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda.
PLoS One
; 14(8): e0221022, 2019.
Article
in English
| MEDLINE | ID: mdl-31398244
19.
Moving to Another World: Understanding the Impact of Clinical Trial Closure on Research Participants Living With HIV in Uganda.
J Assoc Nurses AIDS Care
; 30(5): e96-e108, 2019.
Article
in English
| MEDLINE | ID: mdl-30664024
20.
Perceptions of Strategies and Intervention Approaches for HIV Self-Management among Ugandan Adolescents: A Qualitative Study.
J Int Assoc Provid AIDS Care
; 18: 2325958218823246, 2019.
Article
in English
| MEDLINE | ID: mdl-30798668